Also known as Xeloda
Capecitabine (INN) (Xeloda, Roche) is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouridine (5'-DFUR), to form 5-fluorouracil.Source: Wikipedia
Patients are most commonly prescribed capecitabine to treat colorectal cancer, breast cancer, metastatic cancer, and pancreatic cancer.
Patients taking capecitabine most commonly experience side effects like nausea, anemia, and diarrhea.
|Shortness of breath|
|Alopecia (Loss Of Hair)|
|Abnormal appearing skin|
|Gastrointestinal hemorrhage (GI Bleeding)|